Menu Back toSession-20-Spontaneous-Case-Report

Drug Safety and Pharmacovigilance Across the Product Lifecycle

Build a solid foundation in the key concepts of drug safety and pharmacovigilance throughout the medical product development lifecycle. Learn how to comply with regulatory requirements.


Session 20: Spontaneous Case Report

Session Chair(s)

Jill W. Buckley, PharmD

Jill W. Buckley, PharmD

  • Adjunct Assistant Professor
  • Rutgers, the State University of New Jersey, United States
Attendees will review a spontaneous case report for a fictitious marketed product to determine seriousness, expectedness and regulatory reporting requirements.

Contact us

Registration Questions?

Send Email
1.888.257.6457
+1.215.442.6100


Agenda and Event Logistics

Send Email
+1.215.442.6108